PH21847A - Phenalkoxyalkyl-and phenoxyalkyl-substituted oxiranecarboxylic acids,their use and medicaments containing them - Google Patents

Phenalkoxyalkyl-and phenoxyalkyl-substituted oxiranecarboxylic acids,their use and medicaments containing them

Info

Publication number
PH21847A
PH21847A PH26072A PH26072A PH21847A PH 21847 A PH21847 A PH 21847A PH 26072 A PH26072 A PH 26072A PH 26072 A PH26072 A PH 26072A PH 21847 A PH21847 A PH 21847A
Authority
PH
Philippines
Prior art keywords
phenalkoxyalkyl
phenoxyalkyl
medicaments containing
oxiranecarboxylic acids
substituted oxiranecarboxylic
Prior art date
Application number
PH26072A
Other languages
English (en)
Inventor
Klaus Eistetter
Erich Rapp
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of PH21847A publication Critical patent/PH21847A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/17—Unsaturated ethers containing halogen
    • C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/257—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings
    • C07C43/29—Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings containing halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH26072A 1980-08-25 1981-08-20 Phenalkoxyalkyl-and phenoxyalkyl-substituted oxiranecarboxylic acids,their use and medicaments containing them PH21847A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH639780 1980-08-25
CH152681 1981-03-06

Publications (1)

Publication Number Publication Date
PH21847A true PH21847A (en) 1988-03-17

Family

ID=25687902

Family Applications (1)

Application Number Title Priority Date Filing Date
PH26072A PH21847A (en) 1980-08-25 1981-08-20 Phenalkoxyalkyl-and phenoxyalkyl-substituted oxiranecarboxylic acids,their use and medicaments containing them

Country Status (16)

Country Link
US (1) US4337267A (fr)
EP (1) EP0046590B1 (fr)
JP (1) JPS6059914B2 (fr)
AU (1) AU549447B2 (fr)
CA (1) CA1167050A (fr)
DE (1) DE3170608D1 (fr)
DK (1) DK171890B1 (fr)
ES (1) ES504922A0 (fr)
GR (1) GR75741B (fr)
IE (1) IE51534B1 (fr)
IL (1) IL63627A (fr)
NZ (1) NZ198136A (fr)
PH (1) PH21847A (fr)
PT (1) PT73563B (fr)
WO (1) WO1982000643A1 (fr)
YU (1) YU206681A (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987000751A2 (fr) * 1985-08-02 1987-02-12 Byk Gulden Lomberg Chemische Fabrik Gmbh Utilisation d'acides carboxyliques d'oxirane pour le traitement de l'hyperlipemie
EP0283168A3 (fr) * 1987-03-16 1989-06-14 American Home Products Corporation Carboxylates de fluoroxiranne
US4788304A (en) * 1987-12-07 1988-11-29 American Home Products Corporation Phospholipase A2 inhibitors
DE3906953A1 (de) * 1989-03-04 1990-09-20 Byk Gulden Lomberg Chem Fab Verfahren zur herstellung optisch reiner oxirancarbonsaeuren
US5545672A (en) * 1993-02-11 1996-08-13 The University Of Texas System Treatment of insulin resistance and type 2 diabetes mellitus with a thiol protease inhibitor
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
WO1998000422A1 (fr) * 1996-07-02 1998-01-08 Sang Sup Jew Derive d'acide carboxylique d'oxirane et son procede de fabrication
KR19980028082A (ko) * 1996-10-21 1998-07-15 김박광 혈당 강하 작용을 갖는 신규 옥시란 카복실산의 유도체, 그 제조방법 및 이를 함유하는 당뇨병 치료제
DE19705718A1 (de) 1997-02-14 1998-08-20 Horst P O Dr Wolf Neue Oxirancarbonsäuren zur Behandlung des Diabetes Typ 2 und anderer insulinresistenter Zustände
US5932763A (en) * 1997-05-15 1999-08-03 Bayer Corporation Inhibition of matrix metalloproteases by 2-(ω-arolalkyl)-4-biaryl-4-oxobutyric acids
DE10115938A1 (de) * 2001-03-30 2002-10-10 Medigene Ag Ges Fuer Molekular Verfahren zur Herstellung von Oxirancarbonsäuren und Derivaten davon
CA2460782C (fr) * 2001-09-26 2011-11-08 Emisphere Technologies, Inc. Procede de preparation des acides phenoxy alcanoique, alcenoique et alkynoique et de leurs sels au moyen d'un intermediaire dicarboxylate
WO2004071458A2 (fr) * 2003-02-13 2004-08-26 Albert Einstein College Of Medicine Of Yeshiva University Regulation de la prise alimentaire et de la production de glucose par modulation des niveaux d'acyl-coa gras de chaine longue dans l'hypothalamus
WO2006041922A2 (fr) * 2004-10-08 2006-04-20 Dara Biosciences, Inc. Agents, et procedes d'administration au systeme nerveux central
US20090012067A1 (en) * 2005-02-14 2009-01-08 Luciano Rossetti Modulation of Hypothalamic Atp-Sensitive Potassium Channels
AU2009264237B2 (en) * 2008-06-27 2016-04-14 Meta-Iq Aps Inhibitors of carnitin-palmitoyl-transferase-1 for the treatment and prevention of disorders caused by delipidation of neural tissue
CA2986611C (fr) 2015-06-15 2023-10-03 Nmd Pharma Aps Composes destines a etre utilises dans le traitement de troubles neuromusculaires
US11147788B2 (en) 2017-12-14 2021-10-19 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11591284B2 (en) 2017-12-14 2023-02-28 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11730714B2 (en) 2017-12-14 2023-08-22 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US10385028B2 (en) 2017-12-14 2019-08-20 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1103260A (fr) * 1975-09-22 1981-06-16 Richard J. Mohrbacher Traduction non-disponible
US4196300A (en) * 1975-09-22 1980-04-01 Mcneilabs, Inc. α-Alkyl-substituted glycidates and thioglycidates
US4132719A (en) * 1978-04-20 1979-01-02 Mcneilab Inc. Dibromoalkylglycidic acid derivatives
US4132720A (en) * 1978-04-20 1979-01-02 Mcneil Laboratories, Inc. Alkenylglycidic acid derivatives
EP0025192B1 (fr) * 1979-09-07 1983-05-11 Byk Gulden Lomberg Chemische Fabrik GmbH Acides oxiranne-carboxyliques substitués, procédé pour leur préparation, leur utilisation et médicaments les contenant

Also Published As

Publication number Publication date
DK183882A (da) 1982-04-23
EP0046590A2 (fr) 1982-03-03
IL63627A (en) 1984-11-30
IE811931L (en) 1982-02-25
NZ198136A (en) 1983-12-16
CA1167050A (fr) 1984-05-08
WO1982000643A1 (fr) 1982-03-04
YU206681A (en) 1983-10-31
PT73563A (en) 1981-09-01
JPS57501233A (fr) 1982-07-15
ES8300730A1 (es) 1982-11-16
IL63627A0 (en) 1981-11-30
JPS6059914B2 (ja) 1985-12-27
PT73563B (en) 1983-07-14
ES504922A0 (es) 1982-11-16
IE51534B1 (en) 1987-01-07
DK171890B1 (da) 1997-08-04
GR75741B (fr) 1984-08-02
AU549447B2 (en) 1986-01-30
US4337267A (en) 1982-06-29
AU7447581A (en) 1982-03-04
EP0046590B1 (fr) 1985-05-22
EP0046590A3 (en) 1982-04-07
DE3170608D1 (en) 1985-06-27

Similar Documents

Publication Publication Date Title
US4670444B1 (en) and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
PH21850A (en) Dialkoxypyridines,their use and medicaments containing them
DE3175083D1 (en) Pharmaceutical compounds, their preparation and use
DE3368610D1 (en) Phenyl-1-piperidino-2-propanol derivatives, their preparation and medicaments containing them
JPS5791921A (en) Medicine and manufacture
KE3545A (en) 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridine-3-carboxylic acids,processes for their preparation and medicaments containing these compounds
ZA817187B (en) Medicament based on 2-amino-6-trifluoromethoxy-benzothiazole
EP0050460A3 (en) Tridecyloxy- or tetradecyloxy-propane derivatives, and their use
PH21847A (en) Phenalkoxyalkyl-and phenoxyalkyl-substituted oxiranecarboxylic acids,their use and medicaments containing them
JPS5750913A (en) Nifedipin-containing solid medicine and manufacture
JPS5753473A (en) Novel n-aryl-2-oxazolidinones, manufacture and drug containing them
JPS5718624A (en) Drug and manufacture
JPS5756478A (en) Triazinylaminotriazines, manufacture and use
DE3168902D1 (en) Epoxy-cycloalkylalkanecarboxylic acids, process for their preparation, their use and medicaments containing them
DE2960024D1 (en) Substituted diphenylmethyl-imidazoles, their preparation and medicaments containing them
JPS56139420A (en) Drug
JPS56150012A (en) Isotomic solution medicine
JPS56164191A (en) Theophyllinylmethyldioxolane derivative, its manufacture and medicine
JPS57123190A (en) Novel esters, manufacture and medicine containing same
JPS57118521A (en) Blood products and manufacture
JPS5748993A (en) N-phosphonylcarbonyl-carbamates, manufacture and use
ZA805390B (en) Substituted quinolinone-alkanecarboxylic acids, their preparation and use, and medicaments containing them
MTP884B (en) Pharmaceutical preparationes
ZA811567B (en) 2-penem-3-carboxylic acid derivatives, their preparation and use
DE3167536D1 (en) 3-chloroquinoline derivatives, processes for their preparation and medicaments containing them